SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-084662
Filing Date
2013-11-14
Accepted
2013-11-14 12:09:59
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-22312_110q.htm 10-Q 902124
2 EX-31.1 a13-22312_1ex31d1.htm EX-31.1 10613
3 EX-31.2 a13-22312_1ex31d2.htm EX-31.2 10642
4 EX-32.1 a13-22312_1ex32d1.htm EX-32.1 8920
  Complete submission text file 0001104659-13-084662.txt   8044800

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT xlrn-20130930.xml EX-101.INS 992561
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xlrn-20130930.xsd EX-101.SCH 80598
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xlrn-20130930_cal.xml EX-101.CAL 43993
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xlrn-20130930_def.xml EX-101.DEF 441219
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT xlrn-20130930_lab.xml EX-101.LAB 1272536
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xlrn-20130930_pre.xml EX-101.PRE 668387
Mailing Address 128 SYDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SYDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Filer) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36065 | Film No.: 131218074
SIC: 2836 Biological Products, (No Diagnostic Substances)